Theralase Release FY2020 Audited Financial Statements
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Theralase Release FY2020 Audited Financial Statements
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Theralase Technologies Inc.: Theralase Releases Quarterly Newsletter
® Technologies Inc. (
TSXV:TLT)(
OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (
PDC ) and associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses has released the Company s Quarterly Newsletter (
Newsletter ) which provides updates on the previous quarter and progress on the Phase II Non-Muscle Invasive Bladder Cancer (
NMIBC ) Clinical Study (
Highlights from the Newsletter:
Clinical Study Sites ( CSS )
11 CSS s have been launched in Canada (5) and the US (6) for patient enrollment and treatment for Study II.
Patients Treated
Study II has enrolled and provided the primary study treatment for 18 patients (
Theralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
® Technologies Inc. (
TSXV:TLT)(
OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (
PDC ) and their associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses, announced today that it has executed a Collaborative Research Agreement (
CRA ) with the National Microbiology Laboratory, Public Health Agency of Canada (
PHAC ) for the research and development of a Canadian-based SARS-CoV-2 (
COVID-19 ) vaccine.
Under the terms of the agreement, Theralase
® and PHAC are collaborating on the development and optimization of a COVID-19 vaccine by treating the SARS-CoV-2 virus grown on cell lines with Theralase